| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
“Aboutness” and other Problems of Text Retrieval in the Pharmaceutical Industry
|
Abbott, Robert
|
|
1997
|
31 |
1 |
p. 125-135
|
artikel
|
| 2 |
Accounting for Noncompliance in the Design of Clinical Trials
|
Albert, Jeffrey M.
|
|
1997
|
31 |
1 |
p. 157-165
|
artikel
|
| 3 |
A Matrix Method for the Evaluation of Therapeutic Agents: A Framework Based on Disease Process-Oriented Mechanisms of Drug Action and Their Effectiveness
|
Bjornsson, Thorir D.
|
|
1997
|
31 |
1 |
p. 105-110
|
artikel
|
| 4 |
A Model for Osteoporosis Education of Students and Health Professionals
|
Papaioannou, Alexandra
|
|
1997
|
31 |
1 |
p. 287-291
|
artikel
|
| 5 |
A New and Fast Drug Approval System in Europe
|
Sauer, Fernand
|
|
1997
|
31 |
1 |
p. 1-6
|
artikel
|
| 6 |
An Index of United States Regulations Pertaining to Labeling of Prescription Drugs
|
Curran, Charles F.
|
|
1997
|
31 |
1 |
p. 57-62
|
artikel
|
| 7 |
An Innovative Concept in Pharmaceutical Drug Development
|
Tiggemann, Rolf F.
|
|
1997
|
31 |
1 |
p. 119-124
|
artikel
|
| 8 |
An Integrated Approach to the Preparation of Global CMC Dossiers
|
Karlton, Peter C.
|
|
1997
|
31 |
1 |
p. 237-242
|
artikel
|
| 9 |
Appropriate Endpoints for Renal Transplantation Clinical Trials
|
Ponticelli, Claudio
|
|
1997
|
31 |
1 |
p. 207-212
|
artikel
|
| 10 |
A Proactive Approach to Clinical Trial Material Preparation: The Manufacturing, Packaging, and Labeling Protocol
|
Ehrich, Jan A.
|
|
1997
|
31 |
1 |
p. 213-220
|
artikel
|
| 11 |
A Review of the European Community Regulatory Requirements for Expedited and Periodic ADR Reporting
|
Arnold, Barry D. C.
|
|
1997
|
31 |
1 |
p. 181-186
|
artikel
|
| 12 |
A Simple Three-Step Procedure for Parametric and Nonparametric Assessment of Bioequivalence
|
Vuorinen, Jouni
|
|
1997
|
31 |
1 |
p. 167-180
|
artikel
|
| 13 |
A Translational Approach to Education of Women on Bone Health Issues
|
DiGiorgio-Poll, Susan M.
|
|
1997
|
31 |
1 |
p. 293-294
|
artikel
|
| 14 |
Bar Coding during Clinical Trials: A Feasibility Study
|
Groenewoud, Gerhard
|
|
1997
|
31 |
1 |
p. 229-235
|
artikel
|
| 15 |
Clinical Research in China
|
Wong, Ellick
|
|
1997
|
31 |
1 |
p. 93-95
|
artikel
|
| 16 |
Clinical Trial Safety Surveillance in the New Regulatory and Harmonization Environment: Lessons Learned from the “Fialuridine Crisis”
|
Nickas, James
|
|
1997
|
31 |
1 |
p. 63-70
|
artikel
|
| 17 |
Curriculum Development: Training Primary Care Doctors to Diagnose and Treat Osteoporosis
|
Lipton, Steven E.
|
|
1997
|
31 |
1 |
p. 279-286
|
artikel
|
| 18 |
Development of a Human Growth and Osteoporosis Prevention Curriculum and Computer Program
|
Stern, Lawrence S.
|
|
1997
|
31 |
1 |
p. 311-317
|
artikel
|
| 19 |
Editor's Note
|
Teal, Thomas W.
|
|
1997
|
31 |
1 |
p. 319
|
artikel
|
| 20 |
Educating Young Women about Calcium
|
McMurray, Marybeth
|
|
1997
|
31 |
1 |
p. 269-271
|
artikel
|
| 21 |
FDA Inspection of Investigator Sites in Italy
|
Brunetti, N.
|
|
1997
|
31 |
1 |
p. 187-191
|
artikel
|
| 22 |
FDA Reform: Setting the Stage for Efforts to Reform the Agency
|
Kaitin, Kenneth I
|
|
1997
|
31 |
1 |
p. 27-33
|
artikel
|
| 23 |
Fears, Knowledge, and Perceptions of Osteoporosis among Women
|
Martin, Allison R.
|
|
1997
|
31 |
1 |
p. 301-306
|
artikel
|
| 24 |
Fibrodysplasia Ossificans Progressiva (FOP): The Value of Studying a Rare Disorder
|
Shore, Eileen M.
|
|
1997
|
31 |
1 |
p. 273-277
|
artikel
|
| 25 |
General Medical Practitioners' Approaches to Accessing Animate Sources of Drug Information*
|
Gerrett, David
|
|
1997
|
31 |
1 |
p. 221-227
|
artikel
|
| 26 |
Guest Editor's Note: First Annual Symposium on Curriculum Development in Osteoporosis
|
Giovenella, Albert J.
|
|
1997
|
31 |
1 |
p. 265-267
|
artikel
|
| 27 |
How to Improve the Medical Quality of the Coding Reports Based on Who-Art and Costart Use
|
Fizames, Christian
|
|
1997
|
31 |
1 |
p. 85-92
|
artikel
|
| 28 |
Opportunities in Downsizing and Reengineering for the Quality Assurance Unit
|
Hirsch, Allen F.
|
|
1997
|
31 |
1 |
p. 259-263
|
artikel
|
| 29 |
Orphan Drugs: The Current Situation in the United States, Europe, and Asia
|
Meyers, Abbey S.
|
|
1997
|
31 |
1 |
p. 101-104
|
artikel
|
| 30 |
Outsourcing Management in the Pharmaceutical Industry: The Early Stages at Four United States Companies
|
Daniel, Debbie A.
|
|
1997
|
31 |
1 |
p. 111-118
|
artikel
|
| 31 |
Patient Compliance of Women Taking Estrogen Replacement Therapy
|
Berman, Rayanne S.
|
|
1997
|
31 |
1 |
p. 71-83
|
artikel
|
| 32 |
Physical Rehabilitation of the Osteoporotic Patient
|
Fitzsimmons, Amy
|
|
1997
|
31 |
1 |
p. 307-309
|
artikel
|
| 33 |
Postapproval Changes in the United States—Is Life Getting Easier for Industry?
|
Dumitriu, Helene
|
|
1997
|
31 |
1 |
p. 143-149
|
artikel
|
| 34 |
Preparing for an FDA Advisory Committee Meeting
|
Pines, Wayne L.
|
|
1997
|
31 |
1 |
p. 35-41
|
artikel
|
| 35 |
Pricing and Reimbursement Issues in the European Economic Area
|
Hodges, Christopher J. S.
|
|
1997
|
31 |
1 |
p. 251-258
|
artikel
|
| 36 |
Recent Changes in Clinical Trial Authorization in Eastern Europe
|
Paál, Tamás L.
|
|
1997
|
31 |
1 |
p. 151-155
|
artikel
|
| 37 |
Results of a Data Imaging Pilot Project
|
Lawson, Marie E.
|
|
1997
|
31 |
1 |
p. 193-196
|
artikel
|
| 38 |
Specialized ANTI-HIV Testing: Expediting Preclinical Drug Development
|
Buckheit, Robert W.
|
|
1997
|
31 |
1 |
p. 13-22
|
artikel
|
| 39 |
Student Internships: Mutual Benefits in Osteoporosis Health Care and Research
|
Giovenella, Albert J.
|
|
1997
|
31 |
1 |
p. 295-300
|
artikel
|
| 40 |
Support and Illumination
|
Finney, David J.
|
|
1997
|
31 |
1 |
p. 43-48
|
artikel
|
| 41 |
The CDER Labeling and Nomenclature Committee: Structure, Function, and Process
|
Boring, Daniel L.
|
|
1997
|
31 |
1 |
p. 7-11
|
artikel
|
| 42 |
The Challenge of Auditing Clinical Laboratories
|
Desmet, Marian
|
|
1997
|
31 |
1 |
p. 197-205
|
artikel
|
| 43 |
The Challenge of Managing Quality Control/Quality Assurance for Loosely Structured and Virtual Biopharmaceutical Companies
|
Geigert, John
|
|
1997
|
31 |
1 |
p. 97-100
|
artikel
|
| 44 |
The Global Registration of Zyprexa™ (Olanzapine)
|
Worthen, Sue T.
|
|
1997
|
31 |
1 |
p. 49-55
|
artikel
|
| 45 |
The United States Orphan Drug ACT: Challenges and Success
|
Haffner, Marlene E.
|
|
1997
|
31 |
1 |
p. 23-25
|
artikel
|
| 46 |
Three Principles That Govern FDA Advertising and Promotion Regulation
|
Pines, Wayne L.
|
|
1997
|
31 |
1 |
p. 137-142
|
artikel
|
| 47 |
Validation of Clinical Laboratory Results: Discussion of Essential Validation Elements
|
Libeer, Jean-Claude
|
|
1997
|
31 |
1 |
p. 243-250
|
artikel
|
Tijdschrift beschrijving